ELDN
Price
$2.69
Change
+$0.22 (+8.91%)
Updated
Sep 26 closing price
Capitalization
161.08M
40 days until earnings call
RZLT
Price
$9.34
Change
+$0.57 (+6.50%)
Updated
Sep 26 closing price
Capitalization
848.18M
40 days until earnings call
Interact to see
Advertisement

ELDN vs RZLT

Header iconELDN vs RZLT Comparison
Open Charts ELDN vs RZLTBanner chart's image
Eledon Pharmaceuticals
Price$2.69
Change+$0.22 (+8.91%)
Volume$3.64M
Capitalization161.08M
Rezolute
Price$9.34
Change+$0.57 (+6.50%)
Volume$1.96M
Capitalization848.18M
ELDN vs RZLT Comparison Chart in %
Loading...
ELDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELDN vs. RZLT commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELDN is a Buy and RZLT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ELDN: $2.68 vs. RZLT: $9.36)
Brand notoriety: ELDN and RZLT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELDN: 318% vs. RZLT: 106%
Market capitalization -- ELDN: $147.91M vs. RZLT: $796.42M
ELDN [@Biotechnology] is valued at $147.91M. RZLT’s [@Biotechnology] market capitalization is $796.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELDN’s FA Score shows that 1 FA rating(s) are green whileRZLT’s FA Score has 0 green FA rating(s).

  • ELDN’s FA Score: 1 green, 4 red.
  • RZLT’s FA Score: 0 green, 5 red.
According to our system of comparison, both ELDN and RZLT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELDN’s TA Score shows that 4 TA indicator(s) are bullish while RZLT’s TA Score has 4 bullish TA indicator(s).

  • ELDN’s TA Score: 4 bullish, 2 bearish.
  • RZLT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ELDN is a better buy in the short-term than RZLT.

Price Growth

ELDN (@Biotechnology) experienced а +5.29% price change this week, while RZLT (@Biotechnology) price change was +21.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

ELDN is expected to report earnings on Nov 06, 2025.

RZLT is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RZLT($848M) has a higher market cap than ELDN($161M). RZLT YTD gains are higher at: 90.612 vs. ELDN (-34.830). RZLT has higher annual earnings (EBITDA): -77.12M vs. ELDN (-87.9M). ELDN has more cash in the bank: 108M vs. RZLT (86.9M). ELDN has less debt than RZLT: ELDN (803K) vs RZLT (1.78M). ELDN (0) and RZLT (0) have equivalent revenues.
ELDNRZLTELDN / RZLT
Capitalization161M848M19%
EBITDA-87.9M-77.12M114%
Gain YTD-34.83090.612-38%
P/E Ratio4.14N/A-
Revenue00-
Total Cash108M86.9M124%
Total Debt803K1.78M45%
FUNDAMENTALS RATINGS
ELDN vs RZLT: Fundamental Ratings
ELDN
RZLT
OUTLOOK RATING
1..100
1678
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
42
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
1699
PRICE GROWTH RATING
1..100
8235
P/E GROWTH RATING
1..100
84100
SEASONALITY SCORE
1..100
n/a90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ELDN's Valuation (38) in the Pharmaceuticals Major industry is in the same range as RZLT (42) in the null industry. This means that ELDN’s stock grew similarly to RZLT’s over the last 12 months.

ELDN's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as RZLT (100) in the null industry. This means that ELDN’s stock grew similarly to RZLT’s over the last 12 months.

ELDN's SMR Rating (16) in the Pharmaceuticals Major industry is significantly better than the same rating for RZLT (99) in the null industry. This means that ELDN’s stock grew significantly faster than RZLT’s over the last 12 months.

RZLT's Price Growth Rating (35) in the null industry is somewhat better than the same rating for ELDN (82) in the Pharmaceuticals Major industry. This means that RZLT’s stock grew somewhat faster than ELDN’s over the last 12 months.

ELDN's P/E Growth Rating (84) in the Pharmaceuticals Major industry is in the same range as RZLT (100) in the null industry. This means that ELDN’s stock grew similarly to RZLT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELDNRZLT
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 9 days ago
82%
Bullish Trend 3 days ago
88%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ELDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CMGYX33.140.34
+1.04%
Columbia Select Mid Cap Gro Fd I3
WMMAX16.500.16
+0.98%
TETON Westwood Mighty Mites A
NWAHX23.910.13
+0.55%
Nationwide Janus Henderson Overseas R6
SFILX16.110.08
+0.50%
Schwab Fundamental Intl Sm Eq Idx
FTASX30.86N/A
N/A
Fidelity Advisor Asset Manager 70% M

ELDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELDN has been loosely correlated with NUVL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ELDN jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELDN
1D Price
Change %
ELDN100%
+8.70%
NUVL - ELDN
38%
Loosely correlated
+4.99%
RZLT - ELDN
37%
Loosely correlated
+6.73%
TRDA - ELDN
37%
Loosely correlated
+3.94%
CRNX - ELDN
35%
Loosely correlated
+27.92%
IDYA - ELDN
35%
Loosely correlated
+4.52%
More

RZLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RZLT has been loosely correlated with SYRE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RZLT jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RZLT
1D Price
Change %
RZLT100%
+6.50%
SYRE - RZLT
44%
Loosely correlated
+4.04%
DYN - RZLT
43%
Loosely correlated
+4.53%
TERN - RZLT
43%
Loosely correlated
+2.69%
CRNX - RZLT
43%
Loosely correlated
+27.92%
AVBP - RZLT
42%
Loosely correlated
+5.01%
More